IBM, New York Forge Genomic Medicine Research Partnership; John Kelly III Comments
IBM (NYSE: IBM) and the New York Genome Center have partnered to evaluate the Watson supercomputer’s cognitive system for a genomic research project intended to help clinicians develop treatment methods for cancer patients. NYGC and its medical partners will develop a personalized care for patients with glioblastoma, a type of brain cancer, by using IBM’s Watson […] More